Copernicus Therapeutics awarded SBIR grant to develop episomal vectors for breast cancer therapy Aug. 21, 2000 No Comments
NIH licensing opportunity: system for functional identification of p53 mutations Aug. 17, 2000 No Comments
MGI Pharma and MethylGene to collaborate on DNA MeTase inhibitor development Aug. 16, 2000 No Comments